Modulation of the Effects of Osteoprotegerin (OPG) Ligand in a Human Leukemic Cell Line by OPG and Calcitonin
- 20 December 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 279 (2) , 391-397
- https://doi.org/10.1006/bbrc.2000.3953
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Expression of functional RANK on mature rat and human osteoclastsFEBS Letters, 1999
- Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandProceedings of the National Academy of Sciences, 1999
- A Combination of Osteoclast Differentiation Factor and Macrophage-Colony Stimulating Factor Is Sufficient for both Human and Mouse Osteoclast Formation in VitroEndocrinology, 1998
- Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cellsJournal of Endocrinology, 1998
- Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell CulturesBiochemical and Biophysical Research Communications, 1998
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 1997
- TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T CellsJournal of Biological Chemistry, 1997
- Bone Cells Required for Osteoclastic Resorption but Not for Osteoclastic DifferentiationBiochemical and Biophysical Research Communications, 1996
- Modulation of Osteoclast DifferentiationEndocrine Reviews, 1992
- Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.Proceedings of the National Academy of Sciences, 1990